The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ian Morrissey

GR Micro Ltd.

7-9 William Road

London NW1 3ER

UK

[email]@grmicro.co.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • GR Micro Ltd., 7-9 William Road, London NW1 3ER, UK. 1999 - 2007
  • GR Micro Ltd, London. 2000

References

  1. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents. Morrissey, I., Colclough, A., Northwood, J. Int. J. Antimicrob. Agents (2007) [Pubmed]
  2. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods. Morrissey, I., Robbins, M., Viljoen, L., Brown, D.F. J. Antimicrob. Chemother. (2005) [Pubmed]
  3. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae. Morrissey, I., Tillotson, G. J. Antimicrob. Chemother. (2004) [Pubmed]
  4. Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002. Morrissey, I., Burnett, R., Viljoen, L., Robbins, M. J. Infect. (2004) [Pubmed]
  5. Molecular characterization and antimicrobial susceptibility of fluoroquinolone-resistant or -susceptible Streptococcus pneumoniae from Hong Kong. Morrissey, I., Farrell, D.J., Bakker, S., Buckridge, S., Felmingham, D. Antimicrob. Agents Chemother. (2003) [Pubmed]
  6. Serial passage of Chlamydia spp. in sub-inhibitory fluoroquinolone concentrations. Morrissey, I., Salman, H., Bakker, S., Farrell, D., Bébéar, C.M., Ridgway, G. J. Antimicrob. Chemother. (2002) [Pubmed]
  7. Measurement of the bactericidal activity of fluoroquinolones against Streptococcus pneumoniae using the bactericidal index method. Morrissey, I., George, J.T. Int. J. Antimicrob. Agents (2001) [Pubmed]
  8. Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones. Morrissey, I., George, J.T. J. Antimicrob. Chemother. (2000) [Pubmed]
  9. Bactericidal activity of gemifloxacin and other quinolones against Streptococcus pneumoniae. Morrissey, I., George, J.T. J. Antimicrob. Chemother. (2000) [Pubmed]
  10. The bactericidal activity of gemifloxacin (SB-265805). Morrissey, I., Clark, S., Mathias, I. J. Med. Microbiol. (2000) [Pubmed]
  11. Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteins. Morrissey, I., George, J. Antimicrob. Agents Chemother. (1999) [Pubmed]
 
WikiGenes - Universities